Stock ALRN AILERON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Aileron Therapeutics, Inc.

Equities

ALRN

US00887A2042

Real-time Estimate Cboe BZX
Other stock markets
 18:38:13 29/04/2024 BST 		5-day change 1st Jan Change
4.955 USD -0.90% Intraday chart for Aileron Therapeutics, Inc. +2.74% +60.07%
04-18 Ladenburg Thalmann Adjusts Aileron Therapeutics Price Target to $19 From $9, Maintains Buy Rating MT
04-15 Aileron Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ladenburg Thalmann Adjusts Aileron Therapeutics Price Target to $19 From $9, Maintains Buy Rating
MT
Ladenburg Thalmann Upgrades Aileron Therapeutics to Buy From Neutral, Price Target is $9
MT
HC Wainwright Downgrades Aileron Therapeutics to Neutral From Buy
MT
Jones Trading Downgrades Aileron Therapeutics to Neutral from Buy
MT
HC Wainwright Adjusts Price Target on Aileron Therapeutics to $1 From $2, Reiterates Buy Rating
MT
Ladenburg Thalmann Initiates Coverage on Aileron Therapeutics With Buy Rating, $2 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALRN Stock
  4. News Aileron Therapeutics, Inc.
  5. Analyst Reco.